Literature DB >> 10490267

Degradation of hypochlorite-damaged glucose-6-phosphate dehydrogenase by the 20S proteasome.

O Ullrich1, T Reinheckel, N Sitte, T Grune.   

Abstract

Glucose-6-phosphate dehydrogenase (G6PD) was treated with various concentrations of hypochlorite, which is produced by myeloperoxidase and is one of the most important oxidants during inflammatory processes. Inhibition of enzymatic activity, protein fragmentation, and proteolytic susceptibility toward the isolated 20S proteasome of G6PD were investigated. With rising hypochlorite concentrations, an increased proteasomal degradation of G6PD was measured. This occurred at higher hypochlorite concentrations than G6PD inactivation and at lower levels than G6PD fragmentation. The proteolytic activities of the 20S proteasome itself was determined by degradation of oxidized model proteins and cleavage of the synthetic proteasome substrate suc-LLVY-MCA. Proteasome activities remained intact at hypochlorite concentrations in which G6PD is maximally susceptible to proteasomal degradation. Only higher hypochlorite concentrations could decrease the proteolytic activities of the proteasome, which was accompanied by disintegration and fragmentation of the proteasome and proteasome subunits. Therefore, we conclude that the 20S proteasome can degrade proteins moderately damaged by hypochlorite and could contribute to an increased protein turnover in cells exposed to inflammatory stress.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490267     DOI: 10.1016/s0891-5849(99)00060-x

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  Disruption of protein quality control in Parkinson's disease.

Authors:  Casey Cook; Caroline Stetler; Leonard Petrucelli
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

2.  Characterization of non-covalent oligomers of proteins treated with hypochlorous acid.

Authors:  Anna L P Chapman; Christine C Winterbourn; Stephen O Brennan; T William Jordan; Anthony J Kettle
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

Review 3.  Coenzyme Q10 depletion in medical and neuropsychiatric disorders: potential repercussions and therapeutic implications.

Authors:  Gerwyn Morris; George Anderson; Michael Berk; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-06-13       Impact factor: 5.590

4.  2,3,7,8-Tetrachlorodibenzo-p-dioxin poly(ADP-ribose) polymerase (TiPARP, ARTD14) is a mono-ADP-ribosyltransferase and repressor of aryl hydrocarbon receptor transactivation.

Authors:  Laura MacPherson; Laura Tamblyn; Sharanya Rajendra; Fernando Bralha; J Peter McPherson; Jason Matthews
Journal:  Nucleic Acids Res       Date:  2012-12-28       Impact factor: 16.971

5.  Hyperglycemia impairs proteasome function by methylglyoxal.

Authors:  Markus A Queisser; Dachun Yao; Sven Geisler; Hans-Peter Hammes; Günter Lochnit; Erwin D Schleicher; Michael Brownlee; Klaus T Preissner
Journal:  Diabetes       Date:  2009-12-15       Impact factor: 9.461

6.  Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle.

Authors:  Kristen A Malkus; Elpida Tsika; Harry Ischiropoulos
Journal:  Mol Neurodegener       Date:  2009-06-05       Impact factor: 14.195

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.